Explaining the decision to re-employ the current drug controller general of India, the health ministry has told the ...
India Today on MSN22h
India approves living drug to treat blood cancer: All about Qartemi and how it worksThe second indigenous CAR-T cell therapy, Qartemi, has been approved by India's drug regulator. Qartemi is a "living drug" ...
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...
Therapy will cost Rs 35 to 50 lakh. India sees around 1.20 lakh new blood cancer cases and over 70,000 deaths annually from ...
India's pharmaceutical industry holds immense promise, but experts and stakeholders assert that to unlock its full potential, ...
Inability to provide accurate and timely diagnosis is one of the major contributors to the misuse and overuse of ...
CDSCO releases guidance document to evaluate performance and efficacy of IVDs to combat AMR: Gireesh Babu, New Delhi Monday, January 20, 2025, 08:00 Hrs [IST] The Central Drugs St ...
According to the guidance document, delays in diagnosis, combined with a lack of affordable and reliable diagnostic tools, ...
The proportion of obese Indians has risen from 25 per cent in 2013 to 40 per cent in 2023, highlighting the need for ...
A Robotic-Assisted Internal Mammary Artery Harvesting Telesurgery procedure was successfully completed in 58 minutes.The world’s first Robotic ...
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback